Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company), a vertically integrated multistate cannabis operator and the No. 1 U.S. wholesaler of branded products, today announced its nationwide retail footprint hit 60 operating Sunnyside dispensaries through the opening of its newest stores in West Palm Beach and Winter Park, Florida. These new stores expand Cresco’s Florida retail footprint to 25 dispensaries.
Cresco Labs grows its nationwide retail footprint to 60 dispensaries with recent West Palm Beach and Winter Park, Florida store openings. Pictured: Sunnyside Winter Park. (Photo: Business Wire)
“Having achieved 60 nationwide dispensaries, we’re proud of the progress we’ve made to date investing in our strategic retail footprint to normalize shopping for cannabis and broaden accessibility to high quality products in our brand portfolio,” said Charles Bachtell, Cresco Labs’ CEO & Co-Founder. “Since entering Florida in 2021, we’ve rapidly expanded Sunnyside’s footprint by adding 17 stores in prime locations. With more than 22 million state residents and the number of active patients increasing 71 percent over the past two years, Florida is undoubtedly one of the hottest medical cannabis markets in the country that we’ll continue to go deep in.”
Located at 2710 Okeechobee Blvd., Sunnyside West Palm Beach sits along a primary thoroughfare near Interstate 95 and the downtown area. Sunnyside Winter Park’s address is 591 Semoran Blvd. The store is near the corner of an intersection off State Road 408, a busy expressway that sees 50,000 vehicles per day.
These new locations will offer a wide assortment of cannabis products from the company’s branded portfolio that includes Cresco, One Plant, Supply (High Supply), Good News, Remedi and Sunnyside. Stores also have a curated selection of accessories. Patients can place orders today, both in store and online, through the Sunnyside.shop website. Store hours for both stores are Monday through Saturday, 9 AM to 8 PM, and Sunday, 9 AM to 6 PM.
